Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  203.74
-6.37 (-3.03%)
AAPL  265.27
+0.69 (0.26%)
AMD  195.22
-4.93 (-2.46%)
BAC  51.28
-1.78 (-3.35%)
GOOG  312.47
-2.43 (-0.77%)
META  642.68
-12.98 (-1.98%)
MSFT  385.78
-11.45 (-2.88%)
NVDA  189.95
+0.13 (0.07%)
ORCL  139.34
-8.75 (-5.91%)
TSLA  399.41
-12.41 (-3.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.